2025 annual financial data
Aquestive Therapeutics 2025 Net margin
Direct answer
Net margin was -188.09%.
Operating income was -69.65M USD and net income was -83.78M USD.
Operating cash flow was -52.43M USD.
Get free Aquestive Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 44.55M USD
- Operating income
- -69.65M USD
- Net income
- -83.78M USD
- Operating cash flow
- -52.43M USD
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Aquestive Therapeutics financial years